Modification of Peanut Allergen Ara h 3: Effects on IgE Binding and T Cell Stimulation

Abstract

The engineered hypoallergenic Ara h 3 variant displays two characteristics essential for recombinant allergen immunotherapy; it has a reduced binding capacity for serum IgE from peanut-hypersensitive patients and it can stimulate T-cell proliferation and activation.